Modulation of ozone-induced airway hyperresponsiveness and inflammation by interleukin-13

European Respiratory Journal

Volumn 32, Issue 3, 2008, Pages 571-578

  Williams, A S ^a   Nath, P ^a   Leung, S Y ^a   Khorasani, N ^a   McKenzie, A N J ^b   Adcock, I M ^a   Chung, K F ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Airways hyperresponsiveness; Interleukin 13; Interleukin 4; Neutrophils; Ozone

Indexed keywords

CHEMOKINE; CYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE INDUCED CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; OZONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; KERATINOCYTE; LUNG LAVAGE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH2 CELL; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; METABOLISM;

ANIMALS; BRONCHIAL HYPERREACTIVITY; CHEMOKINE CCL20; INTERLEUKIN-13; INTERLEUKIN-4; MICE; MICE, TRANSGENIC; OZONE;

EID: 58149398544     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00121607     Document Type: Article

References (44)

1. Balmes JR, Aris RM, Chen LL, et al. Effects of ozone on normal and potentially sensitive human subjects. Part I: Airway inflammation and responsiveness to ozone in normal and asthmatic subjects. Res Rep Health Eff Inst 1997; 78: 1-37.
2. Vagaggini B, Carnevali S, Macchioni P, et al. Airway inflammatory response to ozone in subjects with different asthma severity. Eur Respir J 1999; 13: 274-280.
3. Stenfors N, Pourazar J, Blomberg A, et al. Effect of ozone on bronchial mucosal inflammation in asthmatic and healthy subjects. Respir Med 2002; 96: 352-358.
4. Galán I, Tobías A, Banegas JR, Aránguez E. Short-term effects of air pollution on daily asthma emergency room admissions. Eur Respir J 2003; 22: 802-808.
5. Eiswerth ME, Douglass Shaw W, Yen ST. Impacts of ozone on the activities of asthmatics: revisiting the data. J Environ Manage 2005; 77: 56-63.
6. Peel JL, Tolbert PE, Klein M, et al. Ambient air pollution and respiratory emergency department visits. Epidemiology 2005; 16: 164-174.
7. Medina-Ramón M, Zanobetti A, Schwartz J. The effect of ozone and PM10 on hospital admissions for pneumonia and chronic obstructive pulmonary disease: a national multicity study. Am J Epidemiol 2006; 163: 579-588.
8. Fabbri LM, Aizawa H, Alpert SE, et al. Airway hyperresponsiveness and changes in cell counts in bronchoalveolar lavage after ozone exposure in dogs. Am Rev Respir Dis 1984; 129: 288-291.
9. Koto H, Salmon M, Haddad el-B, Huang TJ, Zagorski J, Chung KF. Role of cytokine-induced neutrophil chemoattractant (CINC) in ozone-induced airway inflammation and hyperresponsiveness. Am J Respir Crit Care Med 1997; 156: 234-239.
10. Zhang LY, Levitt RC, Kleeberger SR. Differential susceptibility to ozone-induced airways hyperreactivity in inbred strains of mice. Exp Lung Res 1995; 21: 503-518.
11. Cho HY, Zhang LY, Kleeberger SR. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-α receptors. Am J Physiol Lung Cell Mol Physiol 2001; 280: L537-L546.
12. Moore PE, Church TL, Chism DD, Panettieri RA Jr, Shore SA. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am J Physiol Lung Cell Mol Physiol 2002; 282: L847-L853.
13. 3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol 1986; 60: 1321-1326.
14. Inoue H, Aiziwa H, Nakano H, et al. Nitric oxide synthase inhibitors attenuate ozone-induced airway inflammation in guinea pigs. Possible role of interleukin-8. Am J Respir Crit Care Med 2000; 161: 249-256.
15. Haddad el-B, Salmon M, Koto H, Barnes PJ, Adcock I, Chung KF. Ozone induction of cytokine-induced neutrophil chemoattractant (CINC) and nuclear factor-κb in rat lung: inhibition by corticosteroids. FEBS Lett 1996; 379: 265-268.
16. Bhalla DK, Reinhart PG, Bai C, Gupta SK. Amelioration of ozone-induced lung injury by anti-tumor necrosis factor-α. Toxicol Sci 2002; 69: 400-408.
17. Bhalla DK, Gupta SK. Lung injury, inflammation, and inflammatory stimuli in rats exposed to ozone. J Toxicol Environ Health A 2000; 59: 211-228.
18. Johnston CJ, Stripp BR, Reynolds SD, Avissar NE, Reed CK, Finkelstein JN. Inflammatory and antioxidant gene expression in C57BL/6J mice after lethal and sublethal ozone exposures. Exp Lung Res 1999; 25: 81-97.
19. Pendino KJ, Shuler RL, Laskin JD, Laskin DL. Enhanced production of interleukin-1, tumor necrosis factor-α, and fibronectin by rat lung phagocytes following inhalation of a pulmonary irritant. Am J Respir Cell Mol Biol 1994; 11: 279-286.
20. Peden DB, Setzer RW Jr, Devlin RB. Ozone exposure has both a priming effect on allergen-induced responses and an intrinsic inflammatory action in the nasal airways of perennially allergic asthmatics. Am J Respir Crit Care Med 1995; 151: 1336-1345.
21. Kehrl HR, Peden DB, Ball B, Folinsbee LJ, Horstman D. Increased specific airway reactivity of persons with mild allergic asthma after 7.6 hours of exposure to 0.16 ppm ozone. J Allergy Clin Immunol 1999; 104: 1198-1204.
22. Vagaggini B, Taccola M, Cianchetti S, et al. Ozone exposure increases eosinophilic airway response induced by previous allergen challenge. Am J Respir Crit Care Med 2002; 166: 1073-1077.
23. Wagner JG, Hotchkiss JA, Harkema JR. Enhancement of nasal inflammatory and epithelial responses after ozone and allergen coexposure in Brown Norway rats. Toxicol Sci 2002; 67: 284-294.
24. McKenzie GJ, Fallon PG, Emson CL, Grencis RK, McKenzie AN. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med 1999; 189: 1565-1572.
25. Kuperman DA, Huang X, Koth LL, et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 2002; 8: 885-889.
26. Pope SM, Brandt EB, Mishra A, et al. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J Allergy Clin Immunol 2001; 108: 594-601.
27. Zhu Z, Homer RJ, Wang Z, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999; 103: 779-788.
28. McKenzie GJ, Emson CL, Bell SE, et al. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 1998; 9: 423-432.
29. Emson CL, Bell SE, Jones A, Wisden W, McKenzie AN. Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13. J Exp Med 1998; 188: 399-404.
30. 2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125. Eur J Pharmacol 2005; 506: 273-283.
31. Laporte JC, Moore PE, Baraldo S, et al. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 2001; 164: 141-148.
32. Tliba O, Deshpande D, Chen H, et al. IL-13 enhances agonist-evoked calcium signals and contractile responses in airway smooth muscle. Br J Pharmacol 2003; 140: 1159-1162.
33. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 2004; 202: 175-190.
34. -/- mice. Clin Exp Allergy 2007; 37: 1427-1435.
35. Abonyo BO, Alexander MS, Heiman AS. Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation. Am J Physiol Lung Cell Mol Physiol 2005; 289: L478-L488.
36. Yamamoto S, Kobayashi I, Tsuji K, et al. Upregulation of interleukin-4 receptor by interferon-γ: enhanced interleukin-4-induced eotaxin-3 production in airway epithelium. Am J Respir Cell Mol Biol 2004; 31: 456-462.
37. Holz O, Mücke M, Paasch K, et al. Repeated ozone exposures enhance bronchial allergen responses in subjects with rhinitis or asthma. Clin Exp Allergy 2002; 32: 681-689.
38. Peden DB, Setzer RW Jr, Devlin RB. Ozone exposure has both a priming effect on allergen-induced responses and an intrinsic inflammatory action in the nasal airways of perennially allergic asthmatics. Am J Respir Crit Care Med 1995; 151: 1336-1345.
39. Harper RW, Xu C, Eiserich JP, et al. Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett 2005; 579: 4911-4917.
40. Katsifa H, Tsaparidou S, Diza E, Gil-Lamaignere C, Walsh TJ, Roilides E. Effects of interleukin-13 on antifungal activity of human monocytes against Candida albicans. FEMS Immunol Med Microbiol 2001; 31: 211-217.
41. Sozzani P, Cambon C, Vita N, et al. Interleukin-13 inhibits protein kinase c-triggered respiratory burst in human monocytes. Role of calcium and cyclic AMP. J Biol Chem 1995; 270: 5084-5088.
42. Suresh V, George SC. IL-13 induces formation of reactive oxygen species in lung epithelial cells. Am J Respir Crit Care Med 2007; 175: A175.
43. Huang CD, Tliba O, Panettieri RA Jr, Amrani Y. Bradykinin induces interleukin-6 production in human airway smooth muscle cells: modulation by Th2 cytokines and dexamethasone. Am J Respir Cell Mol Biol 2003; 28: 330-338.
44. Johnston RA, Schwartzman IN, Flynt L, Shore SA. Role of interleukin-6 in murine airway responses to ozone. Am J Physiol Lung Cell Mol Physiol 2005; 288: L390-L397.